Michael K. Rainer
Michael K. Rainer publishes mostly in Psychiatry and Mental health, Physiology and Pharmacology, on topics such as Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #3,747,908 of 7,710,434 ranked researchers
- Rank in Austria
- #22,787 of 43,330
- Works
- 83
- Citations
- 1.3k
- Citations per work
- 15.5
What does Michael K. Rainer research?
Michael K. Rainer's work is mostly in Medicine (32%), Psychology (5%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4958.5%
- Health Sciences3036.6%
- Medicine2732.2%
- Health Professions44.4%
- Social Sciences44.9%
- Psychology44.9%
- 1Psychiatry and Mental health15% of their works
- 2Physiology7% of their works
- 3Pharmacology6% of their works
- 4Clinical Psychology5% of their works
- 5General Health Professions4% of their works
- 6Complementary and alternative medicine4% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Cholinesterase and Neurodegenerative Diseases
- Psychiatric care and mental health services
- Law and Political Science
- Parkinson's Disease Mechanisms and Treatments
- Treatment of Major Depression
- Schizophrenia research and treatment
Which keywords describe Michael K. Rainer's research?
The keywords of their largest research topics: Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Neurodegeneration, Oxidative Stress, Amyloid Hypothesis, Tau Pathology and Acetylcholinesterase.
- Parkinson's Disease
- Depression
- Antidepressant
- Legal Methodology
- Crisis Resolution
- Acetylcholinesterase
- Amyloid Hypothesis
- Neurodegeneration
- Dementia
- Alzheimer's Disease
- Mild Cognitive Impairment
- Oxidative Stress
- Tau Pathology
- Cholinesterase Inhibitors
- Home Treatment
- Party Competition
- Antipsychotic Drugs
- Neurocognitive Deficits
- a-Synuclein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Alzheimer's Disease282 topics
- Dementia201 topic
- Mild Cognitive Impairment201 topic
- Neurodegeneration182 topics
- Oxidative Stress182 topics
- Amyloid Hypothesis141 topic
- Tau Pathology141 topic
- Acetylcholinesterase81 topic
- Cholinesterase Inhibitors81 topic
- Crisis Resolution61 topic
- Home Treatment61 topic
- Legal Methodology51 topic
- Party Competition51 topic
- Antidepressant41 topic
- Antipsychotic Drugs41 topic
- Depression41 topic
- Neurocognitive Deficits41 topic
- Parkinson's Disease41 topic
- a-Synuclein41 topic
Where does Michael K. Rainer work?
Michael K. Rainer's main affiliation in the publication record is Donauspital, Austria.
How many publications and citations does Michael K. Rainer have?
OpenAlex counts 83 works and 1,283 citations for Michael K. Rainer, an h-index of 18, ranking #3,747,908 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael K. Rainer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.